Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Sep 3;9(5):73-86.
doi: 10.1080/19382014.2017.1335842. Epub 2017 Jul 5.

Use of additives, scaffolds and extracellular matrix components for improvement of human pancreatic islet outcomes in vitro: A systematic review

Affiliations
Comparative Study

Use of additives, scaffolds and extracellular matrix components for improvement of human pancreatic islet outcomes in vitro: A systematic review

Natália Emerim Lemos et al. Islets. .

Abstract

Pancreatic islet transplantation is an established treatment to restore insulin independence in type 1 diabetic patients. Its success rates have increased lately based on improvements in immunosuppressive therapies and on islet isolation and culture. It is known that the quality and quantity of viable transplanted islets are crucial for the achievement of insulin independence and some studies have shown that a significant number of islets are lost during culture time. Thus, in an effort to improve islet yield during culture period, researchers have tested a variety of additives in culture media as well as alternative culture devices, such as scaffolds. However, due to the use of different categories of additives or devices, it is difficult to draw a conclusion on the benefits of these strategies. Therefore, the aim of this systematic review was to summarize the results of studies that described the use of medium additives, scaffolds or extracellular matrix (ECM) components during human pancreatic islets culture. PubMed and Embase repositories were searched. Of 5083 articles retrieved, a total of 37 articles fulfilled the eligibility criteria and were included in the review. After data extraction, articles were grouped as follows: 1) "antiapoptotic/anti-inflammatory/antioxidant," 2) "hormone," 3) "sulphonylureas," 4) "serum supplements," and 5) "scaffolds or ECM components." The effects of the reviewed additives, ECM or scaffolds on islet viability, apoptosis and function (glucose-stimulated insulin secretion - GSIS) were heterogeneous, making any major conclusion hard to sustain. Overall, some "antiapoptotic/anti-inflammatory/antioxidant" additives decreased apoptosis and improved GSIS. Moreover, islet culture with ECM components or scaffolds increased GSIS. More studies are needed to define the real impact of these strategies in improving islet transplantation outcomes.

Keywords: additives in cultures; culture of islets; extracellular matrix; human pancreatic islet; islet isolation; scaffolds.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flowchart illustrating the search strategy used to identify studies for inclusion in the systematic review.

Similar articles

Cited by

References

    1. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54:2060-9; PMID:15983207; https://doi.org/10.2337/diabetes.54.7.2060 - DOI - PubMed
    1. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343:230-8; PMID:10911004; https://doi.org/10.1056/NEJM200007273430401 - DOI - PubMed
    1. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, et al.. International trial of the edmonton protocol for islet transplantation. N Engl J Med 2006; 355:1318-30; PMID:17005949; https://doi.org/10.1056/NEJMoa061267 - DOI - PubMed
    1. Barton FB, Rickels MR, Alejandro R, Hering BJ, Wease S, Naziruddin B, Oberholzer J, Odorico JS, Garfinkel MR, Levy M, et al.. Improvement in outcomes of clinical islet transplantation: 1999–2010. Diabetes Care 2012; 35:1436-45; PMID:22723582; https://doi.org/10.2337/dc12-0063 - DOI - PMC - PubMed
    1. Rheinheimer J, Bauer AC, Silveiro SP, Estivalet AA, Boucas AP, Rosa AR, Souza BM, Oliveira FS, Cruz LA, Brondani LA, et al.. Human pancreatic islet transplantation: An update and description of the establishment of a pancreatic islet isolation laboratory. Arch Endocrinol Metab 2015; 59:161-70; PMID:25993680; https://doi.org/10.1590/2359-3997000000030 - DOI - PubMed

MeSH terms

LinkOut - more resources